Clinical trials
Phase 4 Heart Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 3 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 2 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 3 |
| 2024 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Terminated | 5 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
| Recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Weill Medical College of Cornell University | 5 |
| The University of Texas Health Science Center, Houston | 3 |
| Johns Hopkins University | 2 |
| Texas Tech University Health Sciences Center | 2 |
| Abbott Medical Devices | 1 |
| Biosense Webster, Inc. | 1 |
| Brigham and Women's Hospital | 1 |
| Cardica, Inc | 1 |
| Creighton University | 1 |
| Duke University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Diseases | 36 |
| Cardiovascular Diseases | 11 |
| Heart Failure | 8 |
| Coronary Artery Disease | 7 |
| Myocardial Ischemia | 6 |
| Coronary Disease | 4 |
| Vascular Diseases | 4 |
| Arterial Occlusive Diseases | 3 |
| Atherosclerosis | 3 |
| Heart Failure, Diastolic | 3 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.